Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Dual Cord Blood Unit (dCBU) Transplantation Increases Short-Term Morbidity, but Has Similar Long-Term Outcome Compared to Matched Unrelated Donor (MUD) Transplantation After Myeloablative Conditioning.

Matt Kalaycio, MD, Brian J. Bolwell, MD, Lisa Rybicki, MS, Edward Copelan, MD, Hien K. Duong, MD, Brian T. Hill, MD, PhD, Robert M. Dean, MD, Brad Pohlman, MD, Steven Andresen, DO, Shawnda Tench, Ronald Sobecks, MD

Blood (2012) 120 (21): 3137.

https://doi.org/10.1182/blood.V120.21.3137.3137

Published: 2012

Journal Articles

A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Bortezomib for Relapsed/Refractory Acute Myeloid Leukemia

Anjali Advani, MD, Paul Elson, Eric D. Hsi, MD, Randall Davis, Matt Kalaycio, MD, Ronald Sobecks, MD, Edward Copelan, MD, Hien K. Duong, MD, Bethany Foster, Mary Lynn Rush, Leslie Farhat, Mikkael A. Sekeres, MD, MS

Blood (2012) 120 (21): 3595.

https://doi.org/10.1182/blood.V120.21.3595.3595

Published: 2012

Journal Articles

Response to High Dose Cytarabine (HIDAC) As First Salvage for Relapsed Acute Lymphocytic Leukemia in Patients Receiving HIDAC As Initial Therapy

Anjali S. Advani, MD, Holly Gundacker, Nolyn Nyatanga, MD, Paul Elson, Peter J. Rosen, MD, Jennifer Bates, BS, CCRP, Mikkael A. Sekeres, MD, MS, Matt Kalaycio, MD, Ronald Sobecks, MD, Edward Copelan, MD, Frederick R. Appelbaum, MD

Blood (2011) 118 (21): 2594.

https://doi.org/10.1182/blood.V118.21.2594.2594

Published: 2011

Journal Articles

Absolute Lymphocyte Count At Day 28 Independently Predicts Event-Free and Overall Survival in Adults with Newly Diagnosed Acute Lymphocytic Leukemia

Di Sun, Paul Elson, Michaela Liedtke, MD, Bruno C. Medeiros, MD, Marc Earl, PharmD, RPh, Ash A Alizadeh, MD/PhD, Jennifer Bates, BS, CCRP, Mikkael A. Sekeres, MD, MS, Steven E. Coutre, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Edward Copelan, MD, Anjali S. Advani, MD

Blood (2011) 118 (21): 2552.

https://doi.org/10.1182/blood.V118.21.2552.2552

Published: 2011

Journal Articles

Expression of Phosphorylated Signal Transducer and Activator of Transcription 5 (pSTAT5) Is Associated with An Increased Risk of Death In Acute Myeloid Leukemia.

Anna Brady, MD, Sarah Gibson, MD, Lisa Rybicki, MS, Eric Hsi, MD, Edward Copelan, MD, Matt Kalaycio, MD, Mikkael A. Sekeres, MD, MS, Ronald Sobecks, MD, Yogen Saunthararajah, MD, Jennifer Bates, Anjali S. Advani, MD

Blood (2010) 116 (21): 1675.

https://doi.org/10.1182/blood.V116.21.1675.1675

Published: 2010

Journal Articles

Duration of Antecedent Complete Blood Cell Count (CBC) Abnormalities Predicts Response and Survival Rates In De Novo and Secondary AML.

Sanjay R. Mohan, MD, Paul Elson, Ramon V. Tiu, MD, Anjali Advani, MD, Yogen Saunthararajah, MD, Ronald Sobecks, MD, Matt Kalaycio, MD, Edward Copelan, MD, Jaroslaw P Maciejewski, MD, PhD, FACP, Mikkael A. Sekeres, MD, MS

Blood (2010) 116 (21): 1040.

https://doi.org/10.1182/blood.V116.21.1040.1040

Published: 2010

Journal Articles

Prior Therapy with DNA Methyltransferase Inhibitors (DNMTI) Predicts for Lower Remission Rates and Worse Survival In Secondary Acute Myeloid Leukemia Patients (sAML) Receiving Remission Induction Therapy

Sanjay R. Mohan, MD, Alex Fu, Ramon V. Tiu, MD, Edward Copelan, MD, Yogen Saunthararajah, MD, Anjali Advani, MD, Ronald Sobecks, MD, Manual Afable, Ricki Englehaupt, Katarina Paulic, Marc Earl, Pharm., D., R.Ph., Matt Kalaycio, MD, Jaroslaw P Maciejewski, MD, PhD, FACP, Mikkael A. Sekeres, MD, MS

Blood (2010) 116 (21): 4033.

https://doi.org/10.1182/blood.V116.21.4033.4033

Published: 2010

Journal Articles

New TET2 , ASXL1 and CBL Mutations Have Poor Prognostic Impact In Systemic Mastocytosis and Related Disorders

Fabiola Traina, MD, PhD, Ania Jankowska, MSC, Hideki Makishima, MD, PhD, Fred H. Hsieh, MD, Yingchun Han, PhD, Christine O'Keefe, PhD, Yuka Sugimoto, MD, PhD, Sanjay R. Mohan, MD, Hadrian Szpurka, PhD, Courtney Prince, Kathryn Guinta, MSC, Mikkael A. Sekeres, MD, MS, Matt Kalaycio, MD, Alan E. Lichtin, MD, Anjali S. Advani, MD, Edward Copelan, MD, Ronald Sobecks, MD, Jaroslaw P. Maciejewski, MD, PhD, FACP, Ramon V. Tiu, MD

Blood (2010) 116 (21): 3076.

https://doi.org/10.1182/blood.V116.21.3076.3076

Published: 2010

Journal Articles

Prognostic Significance of Histone (H4) Acetylation In Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with Intermediate Risk Cytogenetics

Mazyar Shadman, MD, MPH, Sarah Gibson, MD, Claudiu Cotta, MD, Yogen Saunthararajah, MD, Eric Hsi, MD, Edward Copelan, MD, Matt Kalaycio, MD, Mikkael A. Sekeres, MD, MS, Ronald Sobecks, MD, Meagan Effinger, BA, Anjali S. Advani, MD

Blood (2010) 116 (21): 2736.

https://doi.org/10.1182/blood.V116.21.2736.2736

Published: 2010

Journal Articles

Outcomes In Acute Myeloid Leukemia (AML) Patients Diagnosed with Myeloid Sarcoma with and without Bone Marrow Involvement

Marc Earl, Pharm., D., R.Ph., Alex Fu, Matt Kalaycio, MD, Anjali Advani, MD, Yogen Saunthararajah, MD, Christina Piks, Barb Tripp, Kristy Grimes, Ronald Sobecks, MD, Edward Copelan, MD, Jaroslaw Maciejewski, Mikkael A. Sekeres, MD, MS

Blood (2010) 116 (21): 2165.

https://doi.org/10.1182/blood.V116.21.2165.2165

Published: 2010

Journal Articles

Strong Histone (H4) Acetylation Is Independently Associated with Better Overall Survival in Newly Diagnosed Acute Myeloid Leukemia (AML).

Mazyar Shadman, MD, MPH, Sarah Gibson, MD, Claudiu Cotta, MD, PhD, Eric D. Hsi, MD, Edward Copelan, MD, Matt Kalaycio, MD, Mikkael A. Sekeres, MD, MS, Ronald Sobecks, MD, Yogen Saunthararajah, M.D., Meagan Effinger, B.A., Anjali Advani, MD

Blood (2009) 114 (22): 4681.

https://doi.org/10.1182/blood.V114.22.4681.4681

Published: 2009

Journal Articles

The Value of Post-Remission Therapy in Older Adults with Acute Myeloid Leukemia (AML).

Mikkael A. Sekeres, MD, MS, Alex Z Fu, PhD, Marc Earl, PharmD, Matt Kalaycio, MD, Anjali Advani, MD, Yogen Saunthararajah, M.D., Ronald Sobecks, MD, Edward Copelan, MD

Blood (2009) 114 (22): 1043.

https://doi.org/10.1182/blood.V114.22.1043.1043

Published: 2009

Journal Articles

Race and Intensity of Post-Remission Therapy in Acute Myeloid Leukemia (AML).

Anna K Brady, BS, BA, Alex Z Fu, PhD, Marc Earl, PharmD, Matt Kalaycio, Anjali Advani, MD, Yogen Saunthararajah, M.D., Ronald Sobecks, Edward Copelan, MD, Mikkael A. Sekeres, MD, MS

Blood (2009) 114 (22): 1012.

https://doi.org/10.1182/blood.V114.22.1012.1012

Published: 2009

Journal Articles

Impact on Pulmonary Function of Pre-Transplant Radiotherapy in Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplant (ASCT).

Christy Stotler, DO, Paul Elson, ScD, Brian Bolwell, MD, Matt Kalaycio, MD, Brad Pohlman, MD, Ronald Sobecks, MD, Robert Dean, MD, Steven Andresen, DO, Edward Copelan, MD, Josephine Chan, John Sweetenham, MD

Blood (2008) 112 (11): 3279.

https://doi.org/10.1182/blood.V112.11.3279.3279

Published: 2008

Journal Articles

Birth Order Does Not Affect Outcome in HLA-Identical Sibling Transplantation.

Edward Copelan, MD, Ronald Sobecks, MD, Robert Dean, MD, Lisa Rybicki, Stacey Brown, Matt Kalaycio, MD, Brad Pohlman, MD, John William Sweetenham, MD, Steven Andresen, DO, Brian Bolwell, MD

Blood (2007) 110 (11): 5003.

https://doi.org/10.1182/blood.V110.11.5003.5003

Published: 2007

Journal Articles

Comparison of Prognostic Factors and Outcomes of Patients with Secondary Acute Myeloid Leukemia (AML) Following Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders (MPD), or Therapy-Related AML (t-AML).

Sanjay Mohan, MD, Paul Elson, ScD, Cristina Rodriguez, MD, Rachid Baz, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Anjali Advani, MD, Jaroslaw P. Maciejewski, MD, PhD, Edward Copelan, MD, Mikkael A. Sekeres, MD

Blood (2007) 110 (11): 4292.

https://doi.org/10.1182/blood.V110.11.4292.4292

Published: 2007

Journal Articles

Prognostic Impact of Elevated Pretransplant Serum Ferritin in Allogeneic Hematopoietic Stem Cell Transplantation.

Anuj Mahindra, MD, Brian Bolwell, MD, Ronald Sobecks, MD, Lisa Rybicki, MS, Stacey Brown, Brad Pohlman, MD, Robert Dean, MD, Steve Andresen, DO, Matt Kalaycio, MD, John Sweetenham, MD, Edward Copelan, MD

Blood (2007) 110 (11): 1109.

https://doi.org/10.1182/blood.V110.11.1109.1109

Published: 2007

Journal Articles

Analysis of Factors Influencing Skin Toxicity after Autologous Hematopoeitic Stem Cell Transplant.

Anuj Mahindra, MD, Brian Bolwell, MD, Ronald Sobecks, MD, Lisa Rybicki, MS, Stacey Brown, Brad Pohlman, MD, Matt Kalaycio, MD, Robert Dean, MD, Steve Andresen, DO, John Sweetenham, MD, Edward Copelan, MD

Blood (2007) 110 (11): 2882.

https://doi.org/10.1182/blood.V110.11.2882.2882

Published: 2007

Journal Articles

Elevated Ferritin Is Associated with Poorer Survival Following Nonablative Allogeneic Transplantation.

Anuj Mahindra, MD, Ronald Sobecks, MD, Lisa Rybicki, MS, Stacey Brown, Brad Pohlman, MD, Matt Kalaycio, MD, Robert Dean, MD, Steve Andresen, DO, John Sweetenham, MD, Brian Bolwell, MD, Edward Copelan, MD

Blood (2007) 110 (11): 1986.

https://doi.org/10.1182/blood.V110.11.1986.1986

Published: 2007

Journal Articles

When May Patients Be Considered Cured after Autografting for Hodgkin Lymphoma?.

Robert M. Dean, MD, John W. Sweetenham, MD, Tao Jin, PhD, Stacey Brown, MS, Brad Pohlman, MD, Ronald Sobecks, MD, Matt Kalaycio, MD, Steve Andresen, MD, Edward Copelan, MD, Brian J. Bolwell, MD

Blood (2007) 110 (11): 1909.

https://doi.org/10.1182/blood.V110.11.1909.1909

Published: 2007

NARROW

Dual Cord Blood Unit (dCBU) Transplantation Increases Short-Term Morbidity, but Has Similar Long-Term Outcome Compared to Matched Unrelated Donor (MUD) Transplantation After Myeloablative Conditioning.

A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Bortezomib for Relapsed/Refractory Acute Myeloid Leukemia

Response to High Dose Cytarabine (HIDAC) As First Salvage for Relapsed Acute Lymphocytic Leukemia in Patients Receiving HIDAC As Initial Therapy

Absolute Lymphocyte Count At Day 28 Independently Predicts Event-Free and Overall Survival in Adults with Newly Diagnosed Acute Lymphocytic Leukemia

Expression of Phosphorylated Signal Transducer and Activator of Transcription 5 (pSTAT5) Is Associated with An Increased Risk of Death In Acute Myeloid Leukemia.

Duration of Antecedent Complete Blood Cell Count (CBC) Abnormalities Predicts Response and Survival Rates In De Novo and Secondary AML.

Prior Therapy with DNA Methyltransferase Inhibitors (DNMTI) Predicts for Lower Remission Rates and Worse Survival In Secondary Acute Myeloid Leukemia Patients (sAML) Receiving Remission Induction Therapy

New TET2 , ASXL1 and CBL Mutations Have Poor Prognostic Impact In Systemic Mastocytosis and Related Disorders

Prognostic Significance of Histone (H4) Acetylation In Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with Intermediate Risk Cytogenetics

Outcomes In Acute Myeloid Leukemia (AML) Patients Diagnosed with Myeloid Sarcoma with and without Bone Marrow Involvement

Strong Histone (H4) Acetylation Is Independently Associated with Better Overall Survival in Newly Diagnosed Acute Myeloid Leukemia (AML).

The Value of Post-Remission Therapy in Older Adults with Acute Myeloid Leukemia (AML).

Race and Intensity of Post-Remission Therapy in Acute Myeloid Leukemia (AML).

Impact on Pulmonary Function of Pre-Transplant Radiotherapy in Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplant (ASCT).

Birth Order Does Not Affect Outcome in HLA-Identical Sibling Transplantation.

Comparison of Prognostic Factors and Outcomes of Patients with Secondary Acute Myeloid Leukemia (AML) Following Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders (MPD), or Therapy-Related AML (t-AML).

Prognostic Impact of Elevated Pretransplant Serum Ferritin in Allogeneic Hematopoietic Stem Cell Transplantation.

Analysis of Factors Influencing Skin Toxicity after Autologous Hematopoeitic Stem Cell Transplant.

Elevated Ferritin Is Associated with Poorer Survival Following Nonablative Allogeneic Transplantation.

When May Patients Be Considered Cured after Autografting for Hodgkin Lymphoma?.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only